Earnings · US stocks

Decoy Therapeutics Inc. (DCOY) earnings

Decoy Therapeutics Inc. published its quarterly report on 2026-11-12. The stock moved -10.05% in the 3 trading days after the report.

Report
quarterly report
Published
2026-11-12
Result
Bad / loss
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day-7.58%—
3 days-10.05%—

Report history

Over the last 8 reports, EPS beat the consensus estimate in 5 of them. The stock rose in the 3 trading days after 1 of 8 reports (average -10.62%).

PublishedEPSEPS surprise3 days after30 days after30d vs index
2026-11-12-3.53-36.29%-10.05%——
2026-08-12-4.46-54.86%-2.22%-13.61%-12.92%
2026-05-08-4.18-2.45%-15.73%+4.90%+5.44%
2026-03-3143.10+765.12%-9.81%-26.20%-40.34%
2025-11-14-21.72+99.74%-34.50%-46.00%-48.24%
2024-11-14-136.80+98.58%+2.17%+10.14%+11.01%
2024-08-09-3412.80+64.63%-14.78%-28.70%-35.58%
2024-05-13-590.40+93.88%+0.00%-92.09%-96.81%

The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.

Stock valuations: DCOY

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.